Skip to main content
. 2021 Mar 23;11:649570. doi: 10.3389/fcimb.2021.649570

Figure 1.

Figure 1

Neutralizing antibody titrations. Neutralizing antibodies to SFTSV were evaluated (FRNT50) in serum samples collected from 6 non-surviving patients, 13 serum samples from 5 surviving patients, and 7 serum samples from 5 healthy residents. Individual samples were serially diluted from 1∶20 to 1∶80. Statistically significant differences were found among surviving patients, non-surviving patients, and healthy residents (p <0.05 for all dilution factor).